Last reviewed · How we verify

NCT04048486

Children Born From IVM-CAPA vs IVF or Natural Conception

Completed Last updated 12 October 2020
What this trial tests

trial testing Developmental score according to The Ages & Stages Questionnaires®, Third Edition - ASQ®-3 in IVM in 66 participants. Completed in 15 December 2019.

Timeline
7 August 2019
Primary endpoint
30 September 2019
15 December 2019

Quick facts

Lead sponsorMỹ Đức Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment66
Start date7 August 2019
Primary completion30 September 2019
Estimated completion15 December 2019
Sites1 location across Vietnam

Drugs / interventions tested

Conditions studied

Sponsor

Mỹ Đức Hospital

Who can join

Adults 1 Month to 66 Months, any sex, with IVM or IVF. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

CAPA-IVM is a new promising IVM technique involving the use of a new compound to facilitate the oocyte and embryo competence. CAPA-IVM preserved the maintenance of trans-zonal projections and significantly improved maturation rate and blastocyst yield. NGS analysis of 20 good quality CAPA-IVM blastocysts did not reveal increased aneuploidy compared to age-matched routine ICSI patients. The first CAPA-IVM baby was born in 2017 at My Duc Hospital, Vietnam and up to now, there are 33 babies born from this technique. There is no study to investigate the development of babies born from CAPA-IVM.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Developmental score according to The Ages & Stages Questionnaires®, Third Edition - ASQ®-3

Trials testing the same drug.

Other recruiting trials for IVM

Currently open trials in the same condition.

Other Mỹ Đức Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04048486.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing